PRGO Q4 2021 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q4 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B-14.3% YoY

Gross Profit

$362M32.8% margin

Operating Income

$47M4.2% margin

Net Income

$10M0.9% margin

EPS (Diluted)

$0.24

QoQ Revenue Growth

+6.0%

Cash Flow

Operating Cash Flow

-$105M

Free Cash Flow

-$77M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10.4B

Total Liabilities

$5.3B

Stockholders' Equity

$5.2B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.3B	-14.3%
Gross Profit	$362M	$469M	-22.8%
Operating Income	$47M	-$52M	+189.5%
Net Income	$10M	-$175M	+105.5%

Revenue Segments

Consumer Self-Care Americas

$736M67%

Consumer Self-Care International

$369M33%

Geographic Segments

UNITED STATES

$707M64%

Europe

$355M32%

Other Geographical Areas

$43M4%

IRELAND

$6M1%